BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36799965)

  • 21. Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
    Takami H
    Endocr Pathol; 2003; 14(2):123-31. PubMed ID: 12858002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary Thyroid Carcinoma Associated with Germline RET
    Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ
    Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary medullary thyroid carcinoma: the management dilemma.
    Zhou P; Liu J; Cheng SW; Wang B; Yang R; Peng L
    Fam Cancer; 2012 Jun; 11(2):157-65. PubMed ID: 22183190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Krampitz GW; Norton JA
    Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.
    Kihara M; Miyauchi A; Yoshioka K; Oda H; Nakayama A; Sasai H; Yabuta T; Masuoka H; Higashiyama T; Fukushima M; Ito Y; Kobayashi K; Miya A
    Auris Nasus Larynx; 2016 Oct; 43(5):551-5. PubMed ID: 26837867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype-specific progression of hereditary medullary thyroid cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Hum Mutat; 2018 Jun; 39(6):860-869. PubMed ID: 29656518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma.
    Machens A; Dralle H
    World J Surg; 2007 May; 31(5):957-68. PubMed ID: 17453286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
    Wells SA; Pacini F; Robinson BG; Santoro M
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3149-64. PubMed ID: 23744408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medullary thyroid cancer with RET V804M mutation: more indolent than expected?
    Frisco NA; Gunn AH; Thomas SM; Stang MT; Scheri RP; Kazaure HS
    Surgery; 2023 Jan; 173(1):260-267. PubMed ID: 36150924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
    Marsh DJ; Mulligan LM; Eng C
    Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rare RET Variant p.D707E in a Chinese Pedigree with Hereditary Medullary Thyroid Carcinoma.
    Zhang L; Li X; Li Q; Ge S; Chen M; Huang S; Chen B; Li P; Teng B; Xu J; Zhao S; Qi F; Zhang Y
    Pathobiology; 2017; 84(3):152-160. PubMed ID: 27798940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of medullary thyroid cancer.
    Modigliani E; Franc B; Niccoli-sire P
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):631-49. PubMed ID: 11289739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment.
    Boikos SA; Stratakis CA
    Histol Histopathol; 2008 Jan; 23(1):109-16. PubMed ID: 17952863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.
    Kouvaraki MA; Shapiro SE; Perrier ND; Cote GJ; Gagel RF; Hoff AO; Sherman SI; Lee JE; Evans DB
    Thyroid; 2005 Jun; 15(6):531-44. PubMed ID: 16029119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prophylactic thyroidectomy in children and young people with hereditary medullary thyroid carcinoma: a Chilean experience].
    Ramos C; Ojeda D; Cohn D; Wohllk N
    Rev Med Chil; 2005 Sep; 133(9):1029-36. PubMed ID: 16311694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple endocrine neoplasia type 2: 2007 update.
    Raue F; Frank-Raue K
    Horm Res; 2007; 68 Suppl 5():101-4. PubMed ID: 18174721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.
    Moore SW; Zaahl MG
    Pediatr Surg Int; 2008 May; 24(5):521-30. PubMed ID: 18365214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.